A strict chemical nomenclature is first proposed. It is based on the defini
tions of cannabinoids, psychoactive (THC) and nonpsychoactive (CBD, CBN, an
d THC-11 oic acid), and of identified receptors (AEA and G protein) and the
ir physiological ligands (arachidonyl ethanolamine [AEA] and arachidonyl di
glycerol [2-AG]). THC is the only natural cannabinoid that interacts with a
receptor protein in a stereospecific fashion, a property which is associat
ed with its psychoactivity. Other natural, nonpsychoactive cannabinoids, CB
N and CBD, vary over a wide range of concentration in marihuana preparation
s and antagonize the effects of THC. They also possess biological propertie
s, activating membrane enzymes (phosphorylase and acyltransferase) that inc
rease arachidonic acid biosynthesis.
When THC binds a specific G-protein receptor, a structural change is induce
d that modifies an effector mechanism (e.g., decreased adenylate cyclase ac
tivity). THC does not interact directly with neurotransmitters or neuromodu
lators, but alters their response in a dose-related fashion (e.g., enhancin
g the response of a catechol receptor and decreasing the response of an ace
tylcholine receptor or modulating the response of opioid [mu and. delta] re
ceptors). Also, THC permeates the lipid bilayer and influences the integral
membrane proteins through alteration of the boundary lipid. This effect is
distinct from the mechanism resulting from AEA-G protein binding.
It is proposed that AEA receptor interaction possesses a physiological func
tion, which is to regulate the signaling between boundary lipids and the re
ceptors or enzymes of the membrane in response to physiological stimuli. Th
e boundary lipids surrounding the membrane proteins are the vehicles for th
e signals between the AEA receptor and the neurotransmitter receptors and t
heir binding sites. The change of configuration of the AEA receptor modulat
es the signaling effect of the membrane on its enzymes and. receptors. AEA,
a by-product of the membrane phospholipid, is an indirect signal modulator
of membrane activity. THC can deregulate the physiological signaling role
of the G protein and its boundary lipid bilayer, a fundamental feature of a
ll living cells. This deregulation of membrane signaling by THC results in
partial and discordant effects.